Identifying the unmet health needs of patients with congenital hypogonadotropic hypogonadism using a web-based needs assessment: implications for online interventions and peer-to-peer support

Andrew A Dwyer, Richard Quinton, Diane Morin, Nelly Pitteloud, Andrew A Dwyer, Richard Quinton, Diane Morin, Nelly Pitteloud

Abstract

Background: Patients with rare diseases such as congenital hypogonadotropic hypogonadism (CHH) are dispersed, often challenged to find specialized care and face other health disparities. The internet has the potential to reach a wide audience of rare disease patients and can help connect patients and specialists. Therefore, this study aimed to: (i) determine if web-based platforms could be effectively used to conduct an online needs assessment of dispersed CHH patients; (ii) identify the unmet health and informational needs of CHH patients and (iii) assess patient acceptability regarding patient-centered, web-based interventions to bridge shortfalls in care.

Methods: A sequential mixed-methods design was used: first, an online survey was conducted to evaluate health promoting behavior and identify unmet health and informational needs of CHH men. Subsequently, patient focus groups were held to explore specific patient-identified targets for care and to examine the acceptability of possible online interventions. Descriptive statistics and thematic qualitative analyses were used.

Results: 105 male participants completed the online survey (mean age 37 ± 11, range 19-66 years) representing a spectrum of patients across a broad socioeconomic range and all but one subject had adequate healthcare literacy. The survey revealed periods of non-adherence to treatment (34/93, 37%) and gaps in healthcare (36/87, 41%) exceeding one year. Patient focus groups identified lasting psychological effects related to feelings of isolation, shame and body-image concerns. Survey respondents were active internet users, nearly all had sought CHH information online (101/105, 96%), and they rated the internet, healthcare providers, and online community as equally important CHH information sources. Focus group participants were overwhelmingly positive regarding online interventions/support with links to reach expert healthcare providers and for peer-to-peer support.

Conclusion: The web-based needs assessment was an effective way to reach dispersed CHH patients. These individuals often have long gaps in care and struggle with the psychosocial sequelae of CHH. They are highly motivated internet users seeking information and tapping into online communities and are receptive to novel web-based interventions addressing their unmet needs.

Figures

Figure 1
Figure 1
Study schema. Schematic depicting the sequential explanatory mixed-methods design. (A) First, a quantitative online survey was conducted and statistical analysis performed. (B) Subsequently, qualitative focus groups were conducted to explore the survey findings in detail and identify potential explanatory mechanisms. Asterisks note study stages involving participation of patient community leaders.
Figure 2
Figure 2
Adherence to treatment among CHH men. Patient-reported longest duration off treatment (n = 93). All men had been on treatment for at least 12 months. Only 26% (24/93) of men reported never having a gap in treatment (white bar). In total, 37% (34/93) had a lapse in treatment of more than1 year.
Figure 3
Figure 3
Patient-reported challenges of CHH. Patient-reported challenges represent targets for interventions. Focus group discussions revealed two dominant themes relating to feelings of isolation and shame (depicted by circles). These themes encompassed 4 consistent, inter-related psychosocial challenges related to CHH low self-esteem, body image concerns, feeling left behind by their lack of sexual development, and issues related to anxiety and depression (depicted by diamonds). The shapes are sized according to the frequency of patient comments and overlaps and connected shapes identify co-occurring themes.

References

    1. EURORDIS. The voice of 12,000 patients: Experiences and expectations of rare disease patients on diagnosis and care in Europe. France: Boulogne-Billancourt; 2009.
    1. Holtzclaw Williams P. Policy framework for rare disease health disparities. Policy Polit Nurs Pract. 2011;12:114–118. doi: 10.1177/1527154411404243.
    1. Cohen JS, Biesecker BB. Quality of life in rare genetic conditions: a systematic review of the literature. Am J Med Genet A. 2010;152A:1136–1156. doi: 10.1002/ajmg.a.33380.
    1. Huyard C. What, if anything, is specific about having a rare disorder? Patients' judgements on being ill and being rare. Health Expect. 2009;12:361–370. doi: 10.1111/j.1369-7625.2009.00552.x.
    1. Nettleton S, Watt I, O'Malley L, Duffey P. Understanding the narratives of people who live with medically unexplained illness. Patient Educ Couns. 2005;56:205–210. doi: 10.1016/j.pec.2004.02.010.
    1. Fox S. Peer-to-peer healthcare: Many people - especially those living with chronic or rare diseases - use online connections to supplement professional medical advice. Washington, D.C: Pew Internet; 2011.
    1. Tozzi AE, Mingarelli R, Agricola E, Gonfiantini M, Pandolfi E, Carloni E, Gesualdo F, Dallapiccola B. The internet user profile of Italian families of patients with rare diseases: a web survey. Orphanet J Rare Dis. 2013;8:76. doi: 10.1186/1750-1172-8-76.
    1. Ayme S, Kole A, Groft S. Empowerment of patients: lessons from the rare diseases community. Lancet. 2008;371:2048–2051. doi: 10.1016/S0140-6736(08)60875-2.
    1. Fromantin M, Gineste J, Didier A, Rouvier J. [Impuberism and hypogonadism at induction into military service. Statistical study] Probl Actuels Endocrinol Nutr. 1973;16:179–199.
    1. Brioude F, Bouligand J, Trabado S, Francou B, Salenave S, Kamenicky P, Brailly-Tabard S, Chanson P, Guiochon-Mantel A, Young J. Non-syndromic congenital hypogonadotropic hypogonadism: clinical presentation and genotype-phenotype relationships. Eur J Endocrinol. 2010;162:835–851. doi: 10.1530/EJE-10-0083.
    1. Mitchell AL, Dwyer A, Pitteloud N, Quinton R. Genetic basis and variable phenotypic expression of Kallmann syndrome: towards a unifying theory. Trends Endocrinol Metab. 2011;22:249–258.
    1. Huffer V, Scott WH, Connor TB, Lovice H. Psychological studies of adult male patients with sexual infantilism before and after androgen therapy. Ann Intern Med. 1964;61:255–268. doi: 10.7326/0003-4819-61-2-255.
    1. Smith N, Quinton R. Kallmann syndrome. BMJ. 2012;345:e6971. doi: 10.1136/bmj.e6971.
    1. Aydogan U, Aydogdu A, Akbulut H, Sonmez A, Yuksel S, Basaran Y, Uzun O, Bolu E, Saglam K. Increased frequency of anxiety, depression, quality of life and sexual life in young hypogonadotropic hypogonadal males and impacts of testosterone replacement therapy on these conditions. Endocr J. 2012;59:1099–1105. doi: 10.1507/endocrj.EJ12-0134.
    1. Lasaite L, Ceponis J, Preiksa RT, Zilaitiene B. Impaired emotional state, quality of life and cognitive functions in young hypogonadal men. Andrologia. 2013. Dec 8. doi:10.1111/and.12199. [Epub ahead of print]
    1. Pitteloud N, Hayes FJ, Dwyer A, Boepple PA, Lee H, Crowley WF Jr. Predictors of outcome of long-term GnRH therapy in men with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 2002;87:4128–4136. doi: 10.1210/jc.2002-020518.
    1. Liu PY, Baker HW, Jayadev V, Zacharin M, Conway AJ, Handelsman DJ. Induction of spermatogenesis and fertility during gonadotropin treatment of gonadotropin-deficient infertile men: predictors of fertility outcome. J Clin Endocrinol Metab. 2009;94:801–808. doi: 10.1210/jc.2008-1648.
    1. Warne DW, Decosterd G, Okada H, Yano Y, Koide N, Howles CM. A combined analysis of data to identify predictive factors for spermatogenesis in men with hypogonadotropic hypogonadism treated with recombinant human follicle-stimulating hormone and human chorionic gonadotropin. Fertil Steril. 2009;92:594–604. doi: 10.1016/j.fertnstert.2008.07.1720.
    1. Raivio T, Falardeau J, Dwyer A, Quinton R, Hayes FJ, Hughes VA, Cole LW, Pearce SH, Lee H, Boepple P, Crowley WF Jr, Pitteloud N. Reversal of idiopathic hypogonadotropic hypogonadism. N Engl J Med. 2007;357:863–873. doi: 10.1056/NEJMoa066494.
    1. Dunbar-Jacob J, Erlen JA, Schlenk EA, Ryan CM, Sereika SM, Doswell WM. Adherence in chronic disease. Annu Rev Nurs Res. 2000;18:48–90.
    1. Funnell MM, Anderson RM. MSJAMA: the problem with compliance in diabetes. JAMA. 2000;284:1709. doi: 10.1001/jama.284.13.1709-JMS1004-6-1.
    1. Finkelstein JS, Klibanski A, Neer RM, Greenspan SL, Rosenthal DI, Crowley WF Jr. Osteoporosis in men with idiopathic hypogonadotropic hypogonadism. Ann Intern Med. 1987;106:354–361. doi: 10.7326/0003-4819-106-3-.
    1. Popat VB, Calis KA, Vanderhoof VH, Cizza G, Reynolds JC, Sebring N, Troendle JF, Nelson LM. Bone mineral density in estrogen-deficient young women. J Clin Endocrinol Metab. 2009;94:2277–2283. doi: 10.1210/jc.2008-1878.
    1. Ding EL, Song Y, Malik VS, Liu S. Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA. 2006;295:1288–1299. doi: 10.1001/jama.295.11.1288.
    1. Corona G, Monami M, Rastrelli G, Aversa A, Sforza A, Lenzi A, Forti G, Mannucci E, Maggi M. Type 2 diabetes mellitus and testosterone: a meta-analysis study. Int J Androl. 2011;34:528–540. doi: 10.1111/j.1365-2605.2010.01117.x.
    1. Brand JS, van der Tweel I, Grobbee DE, Emmelot-Vonk MH, van der Schouw YT. Testosterone, sex hormone-binding globulin and the metabolic syndrome: a systematic review and meta-analysis of observational studies. Int J Epidemiol. 2011;40:189–207. doi: 10.1093/ije/dyq158.
    1. Yialamas MA, Dwyer AA, Hanley E, Lee H, Pitteloud N, Hayes FJ. Acute sex steroid withdrawal reduces insulin sensitivity in healthy men with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 2007;92:4254–4259. doi: 10.1210/jc.2007-0454.
    1. Laitinen EM, Hero M, Vaaralahti K, Tommiska J, Raivio T. Bone mineral density, body composition and bone turnover in patients with congenital hypogonadotropic hypogonadism. Int J Androl. 2012;35:534–540. doi: 10.1111/j.1365-2605.2011.01237.x.
    1. Wallerstein NB, Duran B. Using community-based participatory research to address health disparities. Health Promot Pract. 2006;7:312–323. doi: 10.1177/1524839906289376.
    1. COST Action BM1105. [ ]
    1. Young J. Approach to the male patient with congenital hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 2012;97:707–718. doi: 10.1210/jc.2011-1664.
    1. Clinical trials registry of the U.S. National Institutes of Health. [ ]
    1. Chew LD, Bradley KA, Boyko EJ. Brief questions to identify patients with inadequate health literacy. Fam Med. 2004;36:588–594.
    1. Chew LD, Griffin JM, Partin MR, Noorbaloochi S, Grill JP, Snyder A, Bradley KA, Nugent SM, Baines AD, Vanryn M. Validation of screening questions for limited health literacy in a large VA outpatient population. J Gen Intern Med. 2008;23:561–566. doi: 10.1007/s11606-008-0520-5.
    1. Pender NJ, Murdaugh C, Parsons MA. Book Health promotion in nursing practice. 6. Pearson: Upper Saddle River NJ; 2010. Health promotion in nursing practice.
    1. Saldana J. Coding Manual for Qualitative Researchers. Thousand Oaks, CA: Sage; 2009.
    1. Kruer MC, Steiner RD. The role of evidence-based medicine and clinical trials in rare genetic disorders. Clin Genet. 2008;74:197–207. doi: 10.1111/j.1399-0004.2008.01041.x.
    1. Watson MS, Epstein C, Howell RR, Jones MC, Korf BR, McCabe ER, Simpson JL. Developing a national collaborative study system for rare genetic diseases. Genet Med. 2008;10:325–329. doi: 10.1097/GIM.0b013e31817b80fd.
    1. Eysenbach G, Wyatt J. Using the Internet for surveys and health research. J Med Internet Res. 2002;4:E13. doi: 10.2196/jmir.4.2.e13.
    1. Close S, Smaldone A, Fennoy I, Reame N, Grey M. Using information technology and social networking for recruitment of research participants: experience from an exploratory study of pediatric Klinefelter syndrome. J Med Internet Res. 2013;15:e48. doi: 10.2196/jmir.2286.
    1. Ramo DE, Prochaska JJ. Broad reach and targeted recruitment using Facebook for an online survey of young adult substance use. J Med Internet Res. 2012;14:e28. doi: 10.2196/jmir.1878.
    1. Shahani S, Braga-Basaria M, Basaria S. Androgen deprivation therapy in prostate cancer and metabolic risk for atherosclerosis. J Clin Endocrinol Metab. 2008;93:2042–2049. doi: 10.1210/jc.2007-2595.
    1. Hudelson P, Kolly V, Perneger T. Patients' perceptions of discrimination during hospitalization. Health Expect. 2010;13:24–32. doi: 10.1111/j.1369-7625.2009.00577.x.
    1. Kritz M, Gschwandtner M, Stefanov V, Hanbury A, Samwald M. Utilization and perceived problems of online medical resources and search tools among different groups of European physicians. J Med Internet Res. 2013;15:e122. doi: 10.2196/jmir.2436.
    1. PubMed Central. [ ]
    1. Hartzler A, Pratt W. Managing the personal side of health: how patient expertise differs from the expertise of clinicians. J Med Internet Res. 2011;13:e62. doi: 10.2196/jmir.1728.
    1. Lorig K, Ritter PL, Plant K, Laurent DD, Kelly P, Rowe S. The South Australia health chronic disease self-management Internet trial. Health Educ Behav. 2013;40:67–77. doi: 10.1177/1090198112436969.
    1. Archambault PM. WikiBuild: a new application to support patient and health care professional involvement in the development of patient support tools. J Med Internet Res. 2011;13:e114. doi: 10.2196/jmir.1961.
    1. Gupta S, Wan FT, Newton D, Bhattacharyya OK, Chignell MH, Straus SE. WikiBuild: a new online collaboration process for multistakeholder tool development and consensus building. J Med Internet Res. 2011;13:e108. doi: 10.2196/jmir.1833.
    1. World Health Organization (WHO) First International Conference on Health Promotion. Ottawa, Canada: World Helath Organization; 1986. Ottawa Charter for Health Promotion.
    1. Pender NJ, Murdaugh CL, Parsons MA. Health Promotion in Nursing Practice. 6. Upper Saddle River, NJ: Prentice Hall; 2010.
    1. Ho AY, Berggren I, Dahlborg-Lyckhage E. Diabetes empowerment related to pender's health promotion model: a meta-synthesis. Nurs Health Sci. 2010;12:259–267. doi: 10.1111/j.1442-2018.2010.00517.x.
    1. Greenhalgh T. Patient and public involvement in chronic illness: beyond the expert patient. BMJ. 2009;338:b49. doi: 10.1136/bmj.b49.
    1. Howe J. The rise of crowdsourcing. Wired Magazine. 2006;14:1–4.
    1. Swan M. Crowdsourced health research studies: an important emerging complement to clinical trials in the public health research ecosystem. J Med Internet Res. 2012;14:e46. doi: 10.2196/jmir.1988.
    1. Proudfoot J, Parker G, Manicavasagar V, Hadzi-Pavlovic D, Whitton A, Nicholas J, Smith M, Burckhardt R. Effects of adjunctive peer support on perceptions of illness control and understanding in an online psychoeducation program for bipolar disorder: a randomised controlled trial. J Affect Disord. 2012;142:98–105. doi: 10.1016/j.jad.2012.04.007.
    1. van der Wulp I, De Leeuw JR, Gorter KJ, Rutten GE. Effectiveness of peer-led self-management coaching for patients recently diagnosed with Type 2 diabetes mellitus in primary care: a randomized controlled trial. Diabet Med. 2012;29:e390–e397. doi: 10.1111/j.1464-5491.2012.03629.x.
    1. Seybert H. Book Internet use in households and by individuals in 2011 (Editor ed.^eds.) City: European Commission; 2011. Internet use in households and by individuals in 2011.
    1. Napoli PM, Obar JA. Book Mobile Leapfrogging and Digital Divide Policy: Assessing the limitations of mobile Internet access. (Editor ed.^eds.) City: New America Foundation; 2013. Mobile Leapfrogging and Digital Divide Policy: Assessing the limitations of mobile Internet access.
    1. Bedgood R, Sadurski R, Schade RR. The use of the internet in data assimilation in rare diseases. Dig Dis Sci. 2007;52:307–312. doi: 10.1007/s10620-006-9213-2.

Source: PubMed

3
S'abonner